D. Mancini

M. Oz, D. Mancini, Y. Naka, 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Relationship of muscular fatigue to pH and diprotonated Pi in humans: a 31P-NMR study.

B. Chance, D. Mancini, K. McCully, 1988, Journal of applied physiology.

Validation of near-infrared spectroscopy in humans.

L Bolinger, B Chance, J R Wilson, 1994, Journal of applied physiology.

Left Ventricular Assist Devices: A Rapidly Evolving Alternative to Transplant.

D. Mancini, Donna Mancini, Paolo C Colombo, 2015, Journal of the American College of Cardiology.

Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure.

A. Moskowitz, D. Mancini, F. Pagani, 2020, JAMA cardiology.

Hemodynamic Response to Exercise in Patients Supported by Continuous Flow Left Ventricular Assist Devices.

D. Burkhoff, D. Mancini, A. Lala, 2020, JACC. Heart failure.

Sustained Cardiac Recovery Hinges on Timing and Natural History of Underlying Condition

D. Mancini, T. L. Le Jemtel, A. Jaiswal, 2018, The American journal of the medical sciences.

The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy.

John Gorcsan, Henry A Glick, Douglas L Mann, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Effect of CYP2C9 and VKORC1 Gene Variants on Warfarin Response in Patients with Continuous-Flow Left Ventricular Assist Devices

N. Uriel, D. Mancini, Y. Naka, 2016, ASAIO journal.

Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.

Zhezhen Jin, D. Mancini, S. Homma, 2016, International journal of cardiology.

Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure.

D. Mancini, Y. Naka, H. Takayama, 2016, The Journal of thoracic and cardiovascular surgery.

Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).

D. Mancini, Y. Naka, H. Takayama, 2016, Circulation. Heart failure.

Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).

D. Mancini, Y. Naka, H. Takayama, 2016, Circulation. Heart failure.

Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support.

N. Uriel, D. Mancini, B. Kalesan, 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Comparison of outcomes after heart replacement therapy in patients over 65 years old.

D. Mancini, R. Walters, Y. Naka, 2015, The Annals of thoracic surgery.

Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support.

D. Mancini, Y. Naka, H. Takayama, 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome.

D. Mancini, Y. Naka, H. Takayama, 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Bridge-to-Decision Therapy With a Continuous-Flow External Ventricular Assist Device in Refractory Cardiogenic Shock of Various Causes

N. Uriel, T. Ota, D. Mancini, 2014, Circulation: Heart Failure.

Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation.

N. Uriel, D. Mancini, P. Schulze, 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Decision Making in Advanced Heart Failure: A Scientific Statement From the American Heart Association

Harlan M. Krumholz, Nancy R. Cook, Daniel D. Matlock, 2012, Circulation.

Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study.

Nir Uriel, Yoshifumi Naka, Margaret Flannery, 2012, Journal of the American College of Cardiology.

Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis

N. Uriel, D. Mancini, C. Marboe, 2012, European journal of heart failure.

Bridging cardiogenic shock patients with short-term ventricular support at a community hospital to long-term ventricular support at a tertiary hospital.

N. Uriel, D. Mancini, Y. Naka, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device.

Khurram Shahzad, Nir Uriel, Yoshifumi Naka, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Asymmetric Pattern of Cerebrovascular Lesions in Patients After Left Ventricular Assist Device Implantation

T. Ota, D. Mancini, T. Kato, 2012, Stroke.

Selection of Cardiac Transplantation Candidates in 2010

D. Mancini, Donna Mancini, Katherine Lietz, 2010, Circulation.

Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.

N. Uriel, D. Mancini, S. Susen, 2010, Journal of the American College of Cardiology.

Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era: Implications for Patient Selection

Mark S. Slaughter, Leslie W. Miller, James W. Long, 2007, Circulation.

Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.

Nader Moazami, O Howard Frazier, Yoshifumi Naka, 2009, Journal of the American College of Cardiology.

Volumetric intravascular ultrasound assessment of mechanisms and results of stent expansion in heart transplant patients

J. Moses, D. Mancini, G. Mintz, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Value of drug-eluting stents in cardiac transplant recipients.

A. Kirtane, J. Moses, M. Leon, 2009, The American journal of cardiology.

eart Allograft Rejection: Detection With Breath Alkanes in Low evels (the HARDBALL Study)

R. Cataneo, J. Fallon, D. Mancini, 2004 .

Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study).

M. Phillips, R. Cataneo, J. Greenberg, 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Peak VO2 in elderly patients with heart failure.

L. Lund, D. Mancini, 2008, International journal of cardiology.

Patient selection for cardiac transplant in 2012

D. Mancini, Mona Kinkhabwala, 2013, Expert review of cardiovascular therapy.

Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection

Kipp W. Johnson, Fayzan F. Chaudhry, Jessica K De Freitas, 2020, Journal of the American College of Cardiology.

Prognostic Value of an Abnormal Signal‐Averaged Electrocardiogram in Patients With Nonischemic Congestive Cardiomyopathy

D. Mancini, K. L. Wong, M. Simson, 1993, Circulation.

Noninvasive Detection ofSkeletal Muscle Underperfusion WithNear-Infrared Spectroscopy inPatients WithHeartFailure

D. Mancini, Johnr . Wilson, 1989 .

Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity?

V. Fuster, J. Sanz, J. Badimón, 2019, Cardiovascular Drugs and Therapy.

Risk Factors for Mortality with Heart Failure

D. Mancini, K. Aaronson, 2012 .

Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy.

L. Lund, D. Mancini, K. Aaronson, 2003, The American journal of cardiology.

Vasopressor Response to Angiotensin II Infusion in Patients With Chronic Heart Failure Receiving &bgr;-Blockers

C. Lang, D. Mancini, M. Packer, 2003, Circulation.

Usefulness of non-invasive measurement of cardiac output during sub-maximal exercise to predict outcome in patients with chronic heart failure.

C. Lang, D. Mancini, M. Farr, 2009, The American journal of cardiology.

Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure.

C. Lang, D. Mancini, P. Agostoni, 2007, Journal of cardiac failure.

Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.

D. Renlund, H. Valantine, D. Mancini, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure.

R. Califf, C. O'connor, D. Mancini, 2011, Journal of cardiac failure.

Morbidity and mortality in diabetic patients following cardiac transplantation.

C. Lang, D. Mancini, N. Edwards, 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection.

N. Tatonetti, E. Chen, A. Koller, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions.

D. Mancini, M. Maurer, D. Abramov, 2008, The American journal of cardiology.

Estimated Health Care Utilization and Expenditures in Individuals With Heart Failure From the Medical Expenditure Panel Survey

D. Mancini, B. Ferket, A. Lala, 2021, Circulation. Heart failure.

A comparison of atrial arrhythmias after heart or double-lung transplantation at a single center: insights into the mechanism of post-operative atrial fibrillation.

Angelo B. Biviano, D. Mancini, H. Garan, 2009, Journal of the American College of Cardiology.

24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization.

A. Caplan, D. Mancini, L. Stevenson, 1993, Journal of the American College of Cardiology.

Task force 3: Recipient guidelines/prioritization

A. Caplan, D. Mancini, L. Stevenson, 1993 .

Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance.

B. Chance, D. Mancini, J. Wilson, 1988, The American journal of cardiology.

New developments for the detection and treatment of cardiac vasculopathy

Z. Ali, D. Mancini, K. Clerkin, 2017, Current opinion in cardiology.

Comparison Between Cardiac Allograft Vasculopathy and Native Coronary Atherosclerosis by Optical Coherence Tomography.

T. Nazif, Z. Ali, G. Weisz, 2016, The American journal of cardiology.

Increased coronary lipid accumulation in heart transplant recipients with prior high-grade cellular rejection: novel insights from near-infrared spectroscopy

T. Nazif, Z. Ali, G. Weisz, 2016, The International Journal of Cardiovascular Imaging.

Optical Coherence Tomographic Evaluation of Transplant Coronary Artery Vasculopathy With Correlation to Cellular Rejection

T. Nazif, J. Moses, G. Weisz, 2014, Circulation. Cardiovascular interventions.

Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors.

H. Valantine, D. Mancini, R. Starling, 2005, Transplantation proceedings.

Analysis of Skeletal Muscle Torque Capacity and Circulating Ceramides in Patients with Advanced Heart Failure.

D. Forman, D. Mancini, T. Kato, 2016, Journal of cardiac failure.

Intravenous use of amrinone for the treatment of the failing heart.

E. Sonnenblick, D. Mancini, T. LeJemtel, 1985, The American journal of cardiology.

Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment

D. Mancini, S. Pinney, 2004, Current opinion in cardiology.

Drug treatment of clinical problems related to cardiac transplantation.

D. Mancini, S. Hankins, 2002, Heart disease.

Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.

D. Mancini, R. Michler, P. Cannon, 1997, The American journal of cardiology.

Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices

N. Uriel, D. Mancini, J. Albu, 2011, European Journal of Heart Failure.

Peak VO(2): a simple yet enduring standard.

D. Mancini, T. LeJemtel, K. Aaronson, 2000, Circulation.

Rationale for Treatment of Patients With Chronic Heart Failure With Adrenergic Blockade

D. Mancini, J. Sackner-Bernstein, 1995 .

Inotropic Drugs for the Treatment of Heart Failure

D. Mancini, T. LeJemtel, G. Keren, 1985, Journal of clinical pharmacology.

Nonselective β-Adrenergic Blockade With Carvedilol Does Not Hinder the Benefits of Exercise Training in Patients With Congestive Heart Failure

D. Mancini, T. LeJemtel, S. Katz, 1997 .

Clinical Trials The STARBRITE Trial: A Randomized, Pilot Study of B-Type Natriuretic PeptideeGuided Therapy in Patients With Advanced Heart Failure

R. Califf, C. O'connor, D. Mancini, 2011 .

Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery.

M. Oz, D. Mancini, C. Marboe, 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure.

D. Mancini, T. LeJemtel, J. Wexler, 1987, Journal of the American College of Cardiology.

The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.

D. Burkhoff, J. D’Armiento, M. Oz, 2007, Journal of the American College of Cardiology.

Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure.

D. Mancini, G. Jondeau, M. Olivari, 1999, Circulation.

Partial loading of the left ventricle during mechanical assist device support is associated with improved myocardial function, blood flow and metabolism and increased exercise capacity.

M. Oz, D. Mancini, S. Bergmann, 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Excessive weight gain in cardiac transplant recipients.

S. Heymsfield, L. Lund, S. Heshka, 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Effect of dichloroacetate on the exercise performance of patients with heart failure.

D. Mancini, J. Wilson, N. Ferraro, 1988, Journal of the American College of Cardiology.

Utilization of Defibrillators and Resynchronization Therapy at the Time of Evaluation at a Heart Failure and Cardiac Transplantation Center

N. Uriel, D. Mancini, U. Jorde, 2010, Pacing and clinical electrophysiology : PACE.

Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation

D. Mancini, T. Kato, P. Schulze, 2016, BMC Cardiovascular Disorders.

Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes

S. Najjar, D. Mancini, K. Margulies, 2021, The Journal of Heart and Lung Transplantation.

Osteoporosis and bone morbidity in cardiac transplant recipients.

D. Mancini, H. Eisen, P. Callegari, 1994, The American journal of medicine.

Usefulness of peak exercise oxygen consumption and the heart failure survival score to predict survival in patients >65 years of age with heart failure.

L. Lund, D. Mancini, A. Goda, 2009, The American journal of cardiology.

Comparison of peak exercise oxygen consumption and the Heart Failure Survival Score for predicting prognosis in women versus men.

L. Lund, D. Mancini, P. Green, 2007, The American journal of cardiology.

Does Renal Function Deteriorate More Rapidly in Diabetic Cardiac Transplant Recipients?

D. Mancini, Y. Naka, J. Haythe, 2007, Transplantation.

Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.

D. Mancini, L. Martinelli, E. Gronda, 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Outcomes of Adult Patients With Congenital Heart Disease After Heart Transplantation: Impact of Disease Type, Previous Thoracic Surgeries, and Bystander Organ Dysfunction.

E. Bacha, D. Mancini, M. Farr, 2016, Journal of cardiac failure.

Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home.

C. Lang, D. Mancini, N. Edwards, 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Usefulness of two-dimensional echocardiographic parameters of the left side of the heart to predict right ventricular failure after left ventricular assist device implantation.

D. Mancini, S. Homma, T. Kato, 2012, The American journal of cardiology.

Outcomes of Multiple Listing for Adult Heart Transplantation in the United States: Analysis of OPTN Data From 2000 to 2013.

D. Mancini, T. Dardas, P. Schulze, 2015, JACC. Heart failure.

Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era.

N. Uriel, D. Mancini, Y. Naka, 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure.

D. Burkhoff, D. Mancini, M. Maurer, 2010, Congestive heart failure.

Periodontitis and bone metabolism in patients with advanced heart failure and after heart transplantation

D. Mancini, T. Kato, P. Kennel, 2017, ESC heart failure.

Comparison of exercise performance in patients with chronic severe heart failure versus left ventricular assist devices.

M. Oz, D. Mancini, R. Goldsmith, 1998, Circulation.

Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial.

R. Califf, C. O'connor, D. Mancini, 2005, American heart journal.

Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure.

L. Lund, D. Mancini, K. Aaronson, 2005, The American journal of cardiology.

Cardiac Improvement During Mechanical Circulatory Support

D. Mancini, F. Pagani, L. Miller, 2007 .

Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure.

M. Oz, D. Mancini, M. Osbakken, 1998, The Journal of thoracic and cardiovascular surgery.

Increased Levels of Retinol Binding Protein 4 in Patients With Advanced Heart Failure Correct After Hemodynamic Improvement Through Ventricular Assist Device Placement

D. Mancini, T. Kato, P. Schulze, 2012 .

Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support.

Allison R. Schulman, C. Petrilli, M. Oz, 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

(cid:1) -Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure

D. Burkhoff, D. Mancini, S. Reiken, 2003 .

-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure

D. Burkhoff, D. Mancini, S. Reiken, 2003 .

Current experience with left ventricular assist devices in patients with congestive heart failure

M. Oz, D. Mancini, A. Beniaminovitz, 1999, Current cardiology reports.

Listing and treatment of status 1 patients

D. Mancini, S. Hankins, 2001 .

Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients.

M. Oz, D. Mancini, R. John, 1999, Circulation.

Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: Results from the United Network for Organ Sharing database.

N. Uriel, D. Mancini, O. Wever-Pinzon, 2014, The Journal of Heart and Lung Transplantation.

Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation

S. Cremers, D. Mancini, T. Kato, 2012, European journal of heart failure.

Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation

D. Mancini, R. Starling, James B. Young, 2016, Circulation. Heart failure.

Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure

D. Mancini, T. Kato, F. Cheema, 2012, Circulation.

Heart Failure Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure

D. Mancini, T. Kato, F. Cheema, 2012 .

Skeletal Muscle Changes in Chronic Cardiac Disease and Failure.

D. Mancini, P. Kennel, P. Schulze, 2015, Comprehensive Physiology.

Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure.

D. Mancini, T. LeJemtel, G. Jondeau, 1997, Journal of cardiovascular pharmacology.

Sympathetic vasoconstriction during exercise in ambulatory patients with left ventricular failure.

D. Mancini, R. Jones, J. Wilson, 1989, Circulation.

Leptin resistance after heart transplantation

L. Lund, D. Mancini, T. LeJemtel, 2010, European journal of heart failure.

Adipose Tissue Inflammation and Adiponectin Resistance in Patients With Advanced Heart Failure: Correction After Ventricular Assist Device Implantation

D. Mancini, T. Kato, F. Cheema, 2012, Circulation. Heart failure.

Characterization of lymphocyte beta-adrenergic receptors at rest and during exercise in ambulatory patients with chronic congestive heart failure.

P. Molinoff, D. Mancini, J. Wilson, 1989, The American journal of cardiology.

Factors Contributing to t art Failure

D. Mancini, John R. Wilson, 2016 .

Factors contributing to the exercise limitation of heart failure.

D. Mancini, J. Wilson, John R. Wilson, 1993, Journal of the American College of Cardiology.

Cardiopulmonary exercise variables in diastolic versus systolic heart failure.

L. Tavazzi, W. Gaasch, C. Lang, 2008, The American journal of cardiology.

Overcoming Electromagnetic Interference by LVADs on ICD Function by Shielding the ICD Programmer Wand and Extension Cable

D. Mancini, H. Garan, Y. Naka, 2009, Pacing and clinical electrophysiology : PACE.

Dissociation between exercise hemodynamics and exercise capacity in patients with chronic heart failure and marked increase in ejection fraction after treatment with beta-adrenergic receptor antagonists.

D. Mancini, M. Maurer, S. Katz, 2003, American Journal of Cardiology.

The Effect of Body Mass Index on Survival Following Heart Transplantation: Do Outcomes Support Consensus Guidelines?

M. Oz, D. Mancini, M. Russo, 2010, Annals of surgery.

Rationale for treatment of patients with chronic heart failure with adrenergic blockade.

R. Pizov, D. Mancini, J. Sackner-Bernstein, 1996, JAMA.

The Power of Cardiac Output.

D. Mancini, T. LeJemtel, 2019, Journal of cardiac failure.

RE: "Is there a difference between patients with peak oxygen consumption below 10 ml/kg/min versus between 10 and 14 ml/kg/min? Does the "grey zone" really exist?".

L. Lund, D. Mancini, 2011, Transplantation proceedings.

Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure.

C. Lang, D. Mancini, J. Haythe, 2007, The American journal of cardiology.

Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list time.

D. Mancini, K. Aaronson, 1999, Journal of the American College of Cardiology.

Electrical connection of native and transplanted sinus nodes via atrial to atrial pacing improves exercise performance after cardiac transplantation.

D. Mancini, J. Coromilas, M. Galantowicz, 1998, The American journal of cardiology.

Effects of cardiac transplantation on ventilatory response to exercise.

D. Mancini, J. Wilson, K. Marzo, 1992, The American journal of cardiology.

Systemic and regional hemodynamic elfects of captopril and milrinone administered alone and concomitantly in patients with heart failure

D. Mancini, T. LeJemtel, C. Maskin, 2005 .

CI-930, a new cardiotonic and vasodilating agent: hemodynamic comparison to dobutamine and long-term clinical effects.

E. Sonnenblick, D. Mancini, T. LeJemtel, 1988, American heart journal.

Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure.

D. Mancini, T. LeJemtel, C. Maskin, 1985, Circulation.

CONGESTIVE HEART FAILURE Systemic and regional hemodynamic elfects of captopril and milrinone administered alone and concomitantly in patients with heart failure

D. Mancini, T. LeJemtel, C. Maskin, 2022 .

Consensus recommendations for the management of chronic heart failure: Introduction

Thomas D. Giles, William T. Abraham, John B. Kostis, 1999 .

Dobutamine stress echocardiography is inadequate to detect early cardiac allograft vasculopathy.

Z. Ali, D. Mancini, S. Restaino, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Spencer T. Martin, D. Mancini, T. Kato, 2015, Circulation journal : official journal of the Japanese Circulation Society.

Management of pregnancy in the post-cardiac transplant patient.

D. Mancini, M. Abdalla, 2014, Seminars in perinatology.

Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.

A. Neugut, D. Mancini, L. Kellerman, 2009, The American journal of cardiology.

Safety and efficacy of everolimus (RAD) as part of a triple immunosuppressive regimen in de novo cardiac transplant recipients: six-month analysis

H. Valantine, D. Mancini, R. Starling, 2002 .

Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation.

D. Renlund, J. Copeland, M. Carrier, 1999, Transplantation.

Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody.

D. Mancini, S. Itescu, N. Edwards, 2000, The New England journal of medicine.

Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy

D. Burkhoff, M. Oz, D. Mancini, 2003, Circulation.

Contribution of Skeletal Muscle Atrophy to Exercise Intolerance and Altered Muscle Metabolism in Heart Failure

R. Lenkinski, N. Reichek, D. Mancini, 1992, Circulation.

Chapter 19 – Alterations in Diaphragmatic and Skeletal Muscle in Heart Failure

D. Mancini, T. H. Jemtel, 2011 .

Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation

L. Lund, D. Mancini, T. LeJemtel, 2009, European journal of heart failure.

Effect of balloon mitral valvuloplasty on exercise capacity, ventilation and skeletal muscle oxygenation.

D. Mancini, H. Herrmann, K. Marzo, 1993, Journal of the American College of Cardiology.

Treatment of anemia in the patient with heart failure

D. Mancini, Rebecca P. Streeter, 2005, Current treatment options in cardiovascular medicine.

Treatment of anemia in patients with chronic heart failure

D. Mancini, K. Hryniewicz, S. Katz, 2003 .

Effect of erythropoietin on exercise capacity in anemic patients with advanced heart failure.

D. Mancini, C. Kunavarapu, 2003, Kidney international. Supplement.

Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure.

D. Mancini, S. Homma, T. Kato, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Gene therapy for heart failure: an investigational treatment that is coming of age.

D. Mancini, M. Farr, 2010, Revista espanola de cardiologia.

Ventricular assist

T. Ota, D. Forman, D. Mancini, 2014 .

Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure

T. Ota, D. Forman, D. Mancini, 2014, Journal of cachexia, sarcopenia and muscle.

Growth hormone resistance in severe heart failure resolves after cardiac transplantation

L. Lund, D. Mancini, T. LeJemtel, 2009, European journal of heart failure.

Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure.

B. Chance, D. Mancini, J. Wilson, 1990, The American journal of cardiology.

Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.

D. Mancini, T. Kato, P. Schulze, 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Cardiac assist devices for end-stage heart failure.

D. Mancini, M. Williams, M. Oz, 2001, Heart disease.

Assessment of submaximal exercise capacity in patients with left ventricular assist devices.

D. Mancini, K. Reemtsma, D. Williams, 1996, Circulation.

Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity.

D. Mancini, C. Marboe, S. Kim-Schulze, 2004, International immunology.

Impact of Pneumonia in Heart Failure Patients.

D. Mancini, G. Gibson, 2021, Journal of the American College of Cardiology.

HFpEF: is splitting into distinct phenotypes by comorbidities the pathway forward?

D. Mancini, M. Maurer, 2014, Journal of the American College of Cardiology.

New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19

D. Mancini, A. Lala, E. Bagiella, 2021, Journal of the American College of Cardiology.

Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study.

V. Fuster, J. Badimón, D. Mancini, 2021, JACC. Heart failure.

Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk?

M. Oz, D. Mancini, Y. Naka, 2003, The Journal of thoracic and cardiovascular surgery.

Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.

D. Mancini, T. LeJemtel, S. Katz, 1997, Circulation.

Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure?

D. Mancini, K. Aaronson, Keith D. Aaronson, 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Impact of Current Management Practices on Early and Late Death in More Than 500 Consecutive Cardiac Transplant Recipients

M. Oz, D. Mancini, P. Sinha, 2000, Annals of surgery.

Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions

D. Burkhoff, D. Mancini, G. Giustino, 2020, ESC heart failure.

Cardiac transplantation in adult patients with mental retardation: do outcomes support consensus guidelines?

D. Mancini, P. Shapiro, Emma Samelson-Jones, 2012, Psychosomatics.

Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation

D. Mancini, M. Farr, Y. Naka, 2017, ASAIO journal.

Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing).

D. Mancini, Y. Naka, H. Takayama, 2016, Circulation. Heart failure.

The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices.

D. Mancini, Y. Naka, V. Topkara, 2016, JACC. Heart failure.

Factors Associated With Primary Graft Failure After Heart Transplantation

D. Mancini, M. Russo, A. Iribarne, 2010, Transplantation.

Anti-Human Leukocyte Antigen Antibodies are Associated with Restenosis after Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy

D. Mancini, L. Rabbani, R. Sciacca, 2005, Transplantation.

Response to Letter Regarding Article “Adipose Tissue Inflammation and Adiponectin Resistance in Patients With Advanced Heart Failure: Correction After Ventricular Assist Device Implantation”

D. Mancini, T. Kato, F. Cheema, 2012 .

Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.

D. Mancini, Y. Naka, H. Takayama, 2015, The Journal of thoracic and cardiovascular surgery.

Serial assessment of exercise capacity after heart transplantation.

D. Mancini, K. Aaronson, J. Mandak, 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Is the alternate waiting list too high risk? The columbia-presbyterian experience

D. Mancini, A. Kherani, S. Pinney, 2003 .

Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era.

M. Oz, C. R. Smith, D. Mancini, 2001, Journal of the American College of Cardiology.

Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation.

D. Renlund, J. Copeland, M. Carrier, 1999, Transplantation.

Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.

D. Mancini, R. Michler, E. Shane, 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Preoperative Assessment of High-Risk Candidates to Predict Survival After Heart Transplantation

N. Uriel, D. Mancini, T. Kato, 2013, Circulation. Heart failure.

Maximizing donor allocation: A review of UNOS region 9 donor heart turn‐downs

D. Mancini, Leway Chen, A. Gass, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Multivariate analysis of factors affecting waiting time to heart transplantation.

D. Mancini, R. Michler, A. Weinberg, 1996, The Annals of thoracic surgery.

Comparison of Outcomes Following Heart Replacement Therapy in Patients Over 65 Years Old

D. Mancini, Y. Naka, H. Takayama, 2015 .

An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients

D. Mancini, R. Michler, S. Itescu, 1998, The Lancet.

Effect of exercise duration on density and coupling of beta-adrenergic receptors on human mononuclear cells.

P. Molinoff, D. Mancini, J. Wilson, 1989, Journal of applied physiology.

Abstract 2308: Does Peak Oxygen Consumption add to the Seattle Heart Failure Model?

L. Lund, D. Mancini, T. Dardas, 2007 .

Acylation of ghrelin is increased in heart failure and decreases post heart transplantation

L. Lund, D. Mancini, P. Freda, 2014, Scandinavian cardiovascular journal : SCJ.

Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency

D. Mancini, S. Kushwaha, A. Keogh, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial

M. Acker, A. Moskowitz, P. O'Gara, 2019, Journal of the American Medical Association (JAMA).

Left and Right Ventricular Functional Dynamics Determined by Echocardiograms Before and After Lung Transplantation.

D. Mancini, S. Homma, T. Kato, 2015, The American journal of cardiology.

Cardiac Transplantation Using Extended-Donor Criteria Organs for Systemic Amyloidosis Complicated by Heart Failure

D. Mancini, C. Marboe, M. Maurer, 2007, Transplantation.

Transcatheter mitral valve repair for functional mitral regurgitation: Evaluating the evidence.

N. Dickert, M. Mack, M. Acker, 2020, The Journal of thoracic and cardiovascular surgery.

T‐cell post‐transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience

G. Bhagat, D. Mancini, B. Alobeid, 2004, British journal of haematology.

Guillain-Barré Syndrome After Primary Cytomegalovirus Infection in a Patient With a Heart Transplant

D. Mancini, A. Camaj, Solomon W. Bienstock, 2021, JACC. Case reports.

Reply What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients?

V. Fuster, D. Mancini, J. Januzzi, 2020, Journal of the American College of Cardiology.

Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support

S. Najjar, D. Mancini, J. Wald, 2021, Circulation. Heart failure.

Potential for donation after circulatory death heart transplantation in the United States: Retrospective analysis of a limited UNOS dataset

D. Mancini, Leway Chen, G. Stevens, 2020, American Journal of Transplantation.

The Changing Pattern of Humoral Rejection in Cardiac Transplant Recipients

D. Mancini, C. Marboe, S. Itescu, 2007, Transplantation.

Severe coronary artery spasm presenting as Prinzmetal's angina following cardiac transplantation.

A. Kirtane, D. Mancini, P. Parikh, 2018, Cardiovascular revascularization medicine : including molecular interventions.

Continuous‐flow mechanical circulatory support is not associated with early graft failure: An analysis of the International Society for Heart and Lung Transplantation registry

L. Lund, D. Mancini, J. Stehlik, 2019, Clinical transplantation.

Use of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post–Coronavirus Disease

D. Mancini, B. Natelson, A. Lala, 2021, JACC: Heart Failure.

Malignancy Post Heart Transplantation: No Free Lunch.

D. Mancini, V. Rakita, 2018, Journal of the American College of Cardiology.

Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United Network for Organ Sharing Database.

D. Mancini, P. Schulze, Y. Naka, 2015, Transplantation proceedings.

Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation.

B. Levin, D. Mancini, P. Kennel, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19

D. Mancini, G. Giustino, A. Lala, 2020, Circulation: Heart Failure.

Assessment of a University of California, Los Angeles 4‐Variable Risk Score for Advanced Heart Failure

L. Lund, D. Mancini, A. Goda, 2014, Journal of the American Heart Association.

Alteration in systemic vascular resistance and cardiac output during acute cellular rejection and recovery in heart transplant recipients.

G. Sayer, N. Uriel, D. Mancini, 2010, The Journal of Heart and Lung Transplantation.

Cardiac transplantation in over 1000 patients: a single institution experience from Columbia University.

D. Mancini, R. John, S. Itescu, 1999, Clinical transplants.

Hypersensitivity myocarditis and outcome after heart transplantation.

D. Mancini, C. Marboe, Saeko Kanai-Yoshizawa, 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.

D. Mancini, C. Marboe, S. Restaino, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Outcome of patients having heart transplantation for lymphocytic myocarditis.

D. Mancini, T. Kato, C. Marboe, 2013, The American journal of cardiology.

Aortic regurgitation during systolic-phase accompanied by mitral regurgitation in patients with continuous-flow left ventricular assist device.

D. Mancini, S. Homma, F. Sera, 2013, European heart journal cardiovascular Imaging.

adult patients undergoing cardiac transplantation Prolonged donor ischemic time does not adversely affect long-term survival in

M. Oz, D. Mancini, J. Morgan, 2013 .

Prolonged donor ischemic time does not adversely affect long-term survival in adult patients undergoing cardiac transplantation.

M. Oz, D. Mancini, J. Morgan, 2003, The Journal of thoracic and cardiovascular surgery.

216 Effect of LVAD on the Prognostic Value of Baseline GFR for Long Term Renal Function in Patients Undergoing Heart Transplant (HTX)

N. Uriel, D. Mancini, S. Restaino, 2011 .

Should heart transplantation be considered as a treatment option for patients aged 70 years and older?

D. Mancini, J. Morgan, R. John, 2004, The Journal of thoracic and cardiovascular surgery.

Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis.

M. Oz, D. Mancini, J. Morgan, 2003, The Annals of thoracic surgery.

Rapid Deterioration of Hospital-Acquired COVID-19 in a Patient on Extracorporeal Left Ventricular Assist Support

D. Mancini, A. Lala, S. Pinney, 2020, Heart & Lung.

Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.

D. Mancini, E. Shane, E. Stein, 2012, The Journal of clinical endocrinology and metabolism.

Standardized Use of the Stanford Integrated Psychosocial Assessment for Transplantation in LVAD Patients.

D. Mancini, B. Ferket, A. Lala, 2019, Journal of cardiac failure.

The Imperfect Cytokine Storm

D. Mancini, A. Lala, U. Gidwani, 2020, JACC: Case Reports.

New-onset graft dysfunction after heart transplantation--incidence and mechanism-related outcomes.

A. Sinha, D. Mancini, C. Marboe, 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Treatment of anemia in patients with chronic heart failure.

D. Mancini, K. Hryniewicz, S. Katz, 2004, Journal of Cardiac Failure.

National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States.

D. Mancini, O. Wever-Pinzon, Y. Naka, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Peak VO2is superior to 6 minute walk for the prediction of survival in patients with heart failure

D. Mancini, M. Packer, J. Whelan, 1996 .

Human immunodeficiency virus infection and left ventricular assist devices: a case series.

N. Uriel, D. Mancini, S. Restaino, 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Heart transplantation in human immunodeficiency virus-positive patients.

N. Uriel, D. Mancini, M. Farr, 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Bethesda Conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure.

O. Howard Frazier, Bartley P. Griffith, George J. Magovern, 1998, The Annals of thoracic surgery.

Mechanical circulatory support as a bridge to cardiac retransplantation: a single center experience.

D. Mancini, M. Farr, P. Schulze, 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation--single-center retrospective analysis.

D. Mancini, T. Kato, P. Schulze, 2012, Journal of cardiology.

Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure

C. Lang, D. Mancini, S. Katz, 2003, Circulation.

The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction.

D. Mancini, M. Maurer, M. Yushak, 2009, Congestive heart failure.

Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial

Pascal Leprince, Mark Zucker, Yoshifumi Naka, 2015, The Lancet.

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.

E. Tuzcu, D. Mancini, R. Starling, 2003, The New England journal of medicine.

Regional differences in recipient waitlist time and pre- and post-transplant mortality after the 2006 United Network for Organ Sharing policy changes in the donor heart allocation algorithm.

Zhezhen Jin, D. Mancini, P. Schulze, 2014, JACC. Heart failure.

Report from a consensus conference on antibody-mediated rejection in heart transplantation.

A. Angelini, S. Russell, A. Kfoury, 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

arterial and mixed venous blood during exercise Carbon dioxide pressure-concentration relationship in

J. E. Hansen, S. Keteyian, M. Gulati, 2015 .

From the American Heart Association Clinician's Guide to Cardiopulmonary Exercise Testing in Adults: A Scientific Statement

S. Keteyian, M. Gulati, R. Macko, 2013 .

Decision Making in Advanced Heart Failure A Scientific Statement From the American Heart Association Endorsed by Heart Failure Society of America, American Association of Heart Failure Nurses, and Society for Medical Decision Making

N. Cook, L. Allen, H. Krumholz, 2022 .

Heart Association Decision Making in Advanced Heart Failure : A Scientific Statement From the American Print

N. Cook, L. Allen, H. Krumholz, 2012 .

AHA Scientific Statement Decision Making in Advanced Heart Failure

N. Cook, L. Allen, H. Krumholz, 2012 .

Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies.

D. Mancini, F. Cheema, S. Pinney, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Anti-HLA antibodies in heart transplantation.

D. Mancini, C. Marboe, S. Itescu, 2003, Transplant immunology.

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure

Barry Greenberg, D. Mancini, K. Zsebo, 2011, Circulation.

High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells.

D. Mancini, G. Vlad, R. Cortesini, 2003, Transplant immunology.

Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.

D. Mancini, C. Marboe, M. Deng, 2011, Human immunology.

Association of low ejection fraction with impaired verbal memory in older patients with heart failure.

R. Marshall, R. Lazar, D. Mancini, 2011, Archives of neurology.

Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association.

Ross Arena, S. Keteyian, M. Gulati, 2010, Circulation.

Longitudinal profiling of circulating miRNA during cardiac allograft rejection: a proof‐of‐concept study

T. Tuschl, N. Tatonetti, D. Mancini, 2021, ESC heart failure.

Cardiac transplantation in over 2000 patients: a single-institution experience from Columbia University.

N. Uriel, D. Mancini, M. Maurer, 2011, Clinical transplants.

Coronavirus and Cardiometabolic Syndrome

V. Fuster, D. Mancini, J. Narula, 2020, Journal of the American College of Cardiology.

Cardiac transplantation in a patient with protein S deficiency.

D. Mancini, Craig R. Smith, Jonathan M. Chen, 1999, The Annals of thoracic surgery.

Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy.

D. Mancini, C. Marboe, J. Madsen, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.

D. Mancini, T. Kato, P. Schulze, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.

D. Mancini, T. Kato, P. Schulze, 2013, Journal of the American College of Cardiology.

Hemodilution Is Common in Patients With Advanced Heart Failure

L. Lund, D. Mancini, K. Hryniewicz, 2003, Circulation.

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

D. Renlund, H. Valantine, D. Mancini, 1998, Transplantation.

Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy.

M. Oz, D. Mancini, P. Sinha, 2001, The Annals of thoracic surgery.

Intravenous Pulse Administration of Cyclophosphamide Is an Effective and Safe Treatment for Sensitized Cardiac Allograft Recipients

M. Oz, D. Mancini, R. Michler, 2002, Circulation.

Immunoglobulin M-to-Immunoglobulin G Anti-Human Leukocyte Antigen Class II Antibody Switching in Cardiac Transplant Recipients Is Associated With an Increased Risk of Cellular Rejection and Coronary Artery Disease

D. Mancini, R. John, S. Itescu, 2005, Circulation.

Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.

Yoshiaki Kawase, Barry Greenberg, L. Deckelbaum, 2008, Journal of cardiac failure.

Attenuation of the unfolded protein response and endoplasmic reticulum stress after mechanical unloading in dilated cardiomyopathy.

Z. Ali, D. Mancini, H. Sweeney, 2015, American journal of physiology. Heart and circulatory physiology.

Characterization of Myocardial Injury in Patients With COVID-19

Samin K. Sharma, V. Fuster, G. Stone, 2020, Journal of the American College of Cardiology.

Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection

V. Fuster, Z. Fayad, D. Mancini, 2020, medRxiv.

Foundation/American Heart Association Task Force on Practice Guidelines Heart Failure in Adults. A Report of the American College of Cardiology Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of

D. Casey, T. Ganiats, D. Mancini, 2009 .

Diagnosis and Management of Heart Failure in Adults : 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the

C. Yancy, M. Chin, P. Rahko, 2011 .

Cardiac transplantation in patients with hypertrophic cardiomyopathy.

D. Mancini, T. Kato, C. Marboe, 2012, The American journal of cardiology.

Exertional Fatigue Due to Skeletal Muscle Dysfunction in Patients With Heart Failure

D. Mancini, J. Wilson, John R. Wilson, 1993, Circulation.

Heart transplantation in diabetic recipients: a decade review of 161 patients at Columbia Presbyterian.

D. Mancini, J. Morgan, R. John, 2004, The Journal of thoracic and cardiovascular surgery.

Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria.

Ranjit John, D. Mancini, R. John, 2004, Journal of the American College of Cardiology.

Indirect recognition of donor HLA-DR peptides in organ allograft rejection.

D. Mancini, R. Michler, E. Reed, 1996, The Journal of clinical investigation.

Advanced heart failure in patients infected with human immunodeficiency virus: is there equal access to care?

N. Uriel, D. Mancini, S. Restaino, 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Indirect recognition of native HLA alloantigens and B-cell help.

D. Mancini, R. Michler, E. Reed, 1995, Transplantation proceedings.

PRETRANSPLANT CACHEXIA AND MORBID OBESITY ARE PREDICTORS OF INCREASED MORTALITY AFTER HEART TRANSPLANTATION1

M. Oz, D. Mancini, R. John, 2001, Transplantation.

Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients.

D. Mancini, R. John, S. Itescu, 2002, Transplantation proceedings.

Cardiac transplant donor heart allocation based on prospective tissue matching.

L. Edmunds, D. Mancini, H. Eisen, 1994, The Annals of thoracic surgery.

Association of device surface and biomaterials with immunologic sensitization after mechanical support.

M. Oz, D. Mancini, M. Russo, 2008, The Journal of thoracic and cardiovascular surgery.

Preoperative Serum Albumin Levels Predict 1-Year Postoperative Survival of Patients Undergoing Heart Transplantation

Zhezhen Jin, D. Mancini, S. Homma, 2013, Circulation. Heart failure.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

P. Ponikowski, S. Solomon, M. Pfeffer, 2013, European journal of heart failure.

FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART

C. Yancy, M. Chin, Sidney C. Smith, 2009 .

ACCF/AHA Practice Guideline: Focused Update Practice Guideline: Focused Update 2009 Focused Update: ACCF/AHA Guidelin s for the Diagnosis and Management of Heart Failure in Adults

C. Yancy, M. Chin, H. Krumholz, 2009 .

T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy

D. Mancini, C. Marboe, M. Sykes, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist de vice

Silviu Itescu, Margaret Flannery, M. Oz, 1999, The Lancet.

Alternate waiting list strategies for heart transplantation maximize donor organ utilization.

D. Mancini, M. Russo, A. Kherani, 2005, Annals of Thoracic Surgery.

Report from a consensus conference on primary graft dysfunction after cardiac transplantation.

S. Russell, P. Leprince, P. Macdonald, 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Preoperative Proteinuria and Reduced Glomerular Filtration Rate Predicts Renal Replacement Therapy in Patients Supported With Continuous-Flow Left Ventricular Assist Devices

D. Mancini, R. Sladen, J. Radhakrishnan, 2016, Circulation. Heart failure.

Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction.

D. Mancini, M. Farr, F. Cheema, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement.

D. Mancini, T. Kato, M. Maurer, 2014, Journal of cardiac failure.

Effect of Daclizumab induction therapy on the development of cardiac transplant vasculopathy.

D. Mancini, S. Itescu, N. Edwards, 2001, The Journal of Heart and Lung Transplantation.

Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy

D. Mancini, R. John, S. Itescu, 2003, Transplantation.

Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.

D. Mancini, E. Shane, D. McMahon, 2004, The New England journal of medicine.

Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure.

D. Mancini, E. Shane, S. Silverberg, 1997, The American journal of medicine.

Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure.

J. Kovarik, D. Mancini, H. Eisen, 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Exercise and Patients with Heart Failure

D. Mancini, 2017 .

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation.

L. Lund, D. Mancini, A. Goda, 2014, American heart journal.

Value of Peak Exercise Oxygen Consumption Combined With B-type Natriuretic Peptide Levels for Optimal Timing of Cardiac Transplantation

D. Mancini, T. Kato, P. Schulze, 2013, Circulation. Heart failure.

Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation.

D. Mancini, S. Homma, T. Kato, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Prognostic impact of the addition of peak oxygen consumption to the Seattle Heart Failure Model in a transplant referral population.

D. Mancini, T. Dardas, K. Aaronson, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM).

L. Lund, D. Mancini, A. Goda, 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy.

L. Lund, D. Mancini, A. Goda, 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Comparison across races of peak oxygen consumption and heart failure survival score for selection for cardiac transplantation.

L. Lund, D. Mancini, A. Goda, 2010, The American journal of cardiology.

Statement From the American Heart Association Clinician's Guide to Cardiopulmonary Exercise Testing in Adults. A Scientific

M. Gulati, R. Macko, B. Franklin, 2010 .

AHA Scientific Statement Clinician's Guide to Cardiopulmonary Exercise Testing in Adults A Scientific Statement From the American Heart Association

S. Keteyian, M. Gulati, R. Macko, 2010 .

Is ventilatory classification preferable to peak oxygen consumption for risk stratification in heart failure?

D. Mancini, T. LeJemtel, 2007, Circulation.

Survival After Heart Transplantation Is Not Diminished Among Recipients With Uncomplicated Diabetes Mellitus: An Analysis of the United Network of Organ Sharing Database

Yoshifumi Naka, M. Oz, D. Mancini, 2006, Circulation.

Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic Therapy: A Subset Analysis From REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure)

Leslie W. Miller, Deborah D. Ascheim, D. Renlund, 2004, Circulation.

Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart Failure.

D. Mancini, D. Mann, C. Spino, 2021, JACC. Heart failure.

Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL): Rationale, design, baseline characteristics, and inclusion criteria performance.

D. Mancini, D. Mann, L. Stevenson, 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Heart transplant allocation: in desperate need of revision.

D. Mancini, P. Schulze, 2014, Journal of the American College of Cardiology.

Peak Cardiac Power Output, Measured Noninvasively, Is a Powerful Predictor of Outcome in Chronic Heart Failure

C. Lang, D. Mancini, T. Lim, 2009, Circulation. Heart failure.

Outcome in Chronic Heart Failure Peak Cardiac Power Output , Measured Noninvasively

D. Mancini, T. Lim, J. Haythe, 2009 .

Heart failure in women.

L. Lund, D. Mancini, 2004, The Medical clinics of North America.

Diagnosis of Heart Failure

L. Lund, D. Mancini, K. Clerkin, 2019, Heart Failure.

Mechanical Device–Based Methods of Managing and Treating Heart Failure

Daniel Burkhoff, D. Burkhoff, D. Mancini, 2005, Circulation.

Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19

Benjamin S. Glicksberg, V. Fuster, Z. Fayad, 2020, Journal of the American College of Cardiology.

Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation.

D. Mancini, C. Marboe, J. Fan, 2007, Transplant immunology.

Central and peripheral components of cardiac failure.

E. Sonnenblick, D. Mancini, S. Factor, 1986, The American journal of medicine.

Bone loss and turnover after cardiac transplantation.

D. Mancini, R. Michler, E. Shane, 1997, The Journal of clinical endocrinology and metabolism.

Late syphilis in a cardiac transplant patient.

D. Mancini, M. Farr, C. Mangurian, 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Management of Noncardiac Comorbidities in Chronic Heart Failure.

D. Mancini, C. Lang, Farhad R. Chowdhury, 2015, Cardiovascular therapeutics.

Immunologic sensitization in recipients of left ventricular assist devices.

M. Oz, D. Mancini, V. Rao, 2003, The Journal of thoracic and cardiovascular surgery.

Clinical benefits of long-term angiotensin II receptor blockade in patients with severe symptoms of congestive heart failure despite full angiotensin converting enzyme inhibition

D. Mancini, T. LeJemtel, G. Jondeau, 1998 .

Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure.

E. Coyle, S. Montain, D. Mancini, 1989, Circulation.

Mediastinal radiation and adverse outcomes after heart transplantation.

N. Uriel, D. Mancini, M. Farr, 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Respiratory Muscle Function and Dyspnea in Patients With Chronic Congestive Heart Failure

D. Mancini, S. Levine, D. Henson, 1992, Circulation.

Respiratory muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy.

B. Chance, D. Mancini, J. Wilson, 1991, Journal of the American College of Cardiology.

Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.

D. Mancini, K. Zsebo, R. Hajjar, 2009, Journal of cardiac failure.

Vascular inflammation and abnormal aortic histomorphometry in patients after pulsatile- and continuous-flow left ventricular assist device placement.

D. Mancini, T. Kato, P. Kennel, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Supplementation of L-Alanyl-L-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure

D. Forman, D. Mancini, T. Kato, 2015, Circulation. Heart failure.

Outcome after orthotopic cardiac transplantation in adults with congenital heart disease.

D. Mancini, R. Michler, D. Hsu, 1999, Circulation.

Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group

O H Frazier, D. Mancini, F. Pagani, 2007, Circulation.

LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery.

Daniel Burkhoff, D. Burkhoff, D. Mancini, 2006, Journal of cardiac failure.

Management of Comorbidities in Heart Failure

C. Lang, D. Mancini, 2008 .

Cardiac rehabilitation exercise and self-care for chronic heart failure.

S. Keteyian, M. Rich, G. Balady, 2013, JACC. Heart failure.

Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure.

L. Lund, D. Mancini, S. Reiken, 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Detection of skeletal muscle fatigue in patients with heart failure using electromyography.

D. Mancini, J. Wilson, M. Simson, 1992, The American journal of cardiology.

Management of Non-cardiac Co-morbidities in Chronic Heart Failure

C. Lang, D. Mancini, 2015 .

New positive inotropic drugs for the treatment of congestive heart failure.

E. Sonnenblick, D. Mancini, T. LeJemtel, 1985, The American journal of cardiology.

Noninvasive detection of skeletal muscle underperfusion with near-infrared spectroscopy in patients with heart failure.

B Chance, J R Wilson, B. Chance, 1989, Circulation.

Application of near infrared spectroscopy to the evaluation of exercise performance and limitations in patients with heart failure.

D. Mancini, 1997, Journal of biomedical optics.

In Vivo Magnetic Resonance Spectroscopy Measurement of Deoxymyoglobin During Exercise in Patients With Heart Failure: Demonstration of Abnormal Muscle Metabolism Despite Adequate Oxygenation

D. Mancini, J. Leigh, L. Bolinger, 1994, Circulation.

New methodologies to accurately assess circulating active transforming growth factor‐&bgr;1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices

R. Varshney, D. Mancini, B. Coller, 2017, Translational research : the journal of laboratory and clinical medicine.

Donna Mancini and Daniel Burkhoff Based Methods of Managing and Treating Heart Failure − Mechanical Device

D. Burkhoff, D. Mancini, 2005 .

The mechanism of extertional fatigue in heart failure.

D. Mancini, J. Wilson, 1990, Cardioscience.

Long-Term Survival After Cardiac Retransplantation: A Twenty-Year Single-Center

M. Oz, D. Mancini, Craig R. Smith, 2013 .

Long-term survival after cardiac retransplantation: a twenty-year single-center experience.

M C Oz, S Itescu, M. Oz, 1999, The Journal of thoracic and cardiovascular surgery.

Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry.

L. Sleeper, D. Mancini, M. Klapholz, 2004, Journal of the American College of Cardiology.

Prediction of heart transplant rejection with a breath test for markers of oxidative stress.

M. Phillips, R. Cataneo, J. Greenberg, 2004, The American journal of cardiology.

Pilot study of guided imagery use in patients with severe heart failure.

M. Oz, D. Mancini, A. Beniaminovitz, 2000, The American journal of cardiology.

&bgr;-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure

D. Burkhoff, D. Mancini, S. Reiken, 2003, Circulation.

Sleep disordered breathing in patients with acutely decompensated heart failure.

D. Mancini, R. Basner, P. Green, 2009, Sleep medicine.

Resting myocardial blood flow and metabolism predicts improved native left ventricular output and the ability to exercise with weaning in patients with the TCI heartmate left ventricular assist device

M. Oz, D. Mancini, S. Bergmann, 1999 .

Prevalence and timing of bend relief disconnection in patients supported by the late version HeartMate II left ventricular assist device.

N. Uriel, T. Ota, G. Pearson, 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Validity and Reliability of a Novel Slow Cuff-Deflation System for Noninvasive Blood Pressure Monitoring in Patients With Continuous-Flow Left Ventricular Assist Device

N. Uriel, D. Mancini, Y. Naka, 2013, Circulation. Heart failure.

Randomized Trial of Empagliflozin in Non-Diabetic Patients with Heart Failure and Reduced Ejection Fraction.

V. Fuster, J. Sanz, J. Badimón, 2020, Journal of the American College of Cardiology.

Fracture after cardiac transplantation: a prospective longitudinal study.

D. Mancini, R. Michler, E. Shane, 1996, The Journal of clinical endocrinology and metabolism.

Treating Anemia in Older Adults With Heart Failure With a Preserved Ejection Fraction With Epoetin Alfa: Single-blind Randomized Clinical Trial of Safety and Efficacy

B. Chakraborty, D. Mancini, M. Maurer, 2013, Circulation. Heart failure.

Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes.

D. Mancini, K. Hryniewicz, S. Katz, 2004, The American journal of cardiology.

What is the relationship between cardiac and peripheral ghrelin production? Reply

L. Lund, D. Mancini, P. Freda, 2009 .

Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure.

C. Petrilli, D. Mancini, E. Shane, 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction.

Zhezhen Jin, D. Mancini, T. Kato, 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

A multicenter study of noninvasive cardiac output by bioreactance during symptom-limited exercise.

D. Burkhoff, J. Myers, D. Mancini, 2009, Journal of cardiac failure.

Atrial Fibrillation in Patients With Left Ventricular Assist Devices: Incidence, Predictors, and Clinical Outcomes.

Angelo B. Biviano, D. Mancini, H. Garan, 2016, JACC. Clinical electrophysiology.

Impact of Center Volume on Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy: Analysis of the Thoratec HeartMate Registry, 1998 to 2005

A. Kfoury, D. Mancini, M. Slaughter, 2009, Circulation. Heart failure.

Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices.

Nir Uriel, Yoshifumi Naka, N. Uriel, 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation.

N. Uriel, D. Mancini, S. Homma, 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Sex differences in patient acceptance of cardiac transplant candidacy.

D. Mancini, J. Goin, K. Aaronson, 1995, Circulation.

Report From a Forum on US Heart Allocation Policy

D. Mancini, J. Rogers, J. Kobashigawa, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Clinical Perspective on P 263 Methods Study Design

B. Chakraborty, D. Mancini, M. Maurer, 2022 .

Efficacy of combined diuretic therapy with metolazone and furosemide in patients with refractory congestive heart failure

D. Mancini, T. LeJemtel, B. Chadwick, 1986 .

Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.

I. Piña, D. Mancini, K. Ferdinand, 2014, The American journal of cardiology.

Use of a Wearable Defibrillator in Terminating Tachyarrhythmias in Patients at High Risk for Sudden Death:

Mark Harvey, Arthur J Moss, Srinivas Murali, 2004, Pacing and clinical electrophysiology : PACE.

In vivo comparison between cardiac allograft vasculopathy and native atherosclerosis using near-infrared spectroscopy and intravascular ultrasound.

T. Nazif, Z. Ali, G. Weisz, 2015, European heart journal cardiovascular Imaging.

Identifying Ambulatory Advanced Heart Failure Patients at High Risk for Death, LVAD or Transplant at 1-year: How Did the REVIVAL Eligibility Criteria Perform?

D. Mancini, D. Mann, L. Stevenson, 2018 .

Alloantibodies in heart transplantation.

D. Mancini, C. Marboe, S. Itescu, 2009, Human immunology.

419: Heart Transplantation in HIV Positive Patients

N. Uriel, D. Mancini, M. Farr, 2009 .

Impairment of Myocardial Glutamine Homeostasis Induced By Suppression of the Amino Acid Carrier SLC1A5 in Failing Myocardium.

D. Mancini, P. Kennel, P. Schulze, 2019, Circulation. Heart failure.

Discontinuing Antiresorptive Therapy One Year after Cardiac Transplantation: Effect on Bone Density and Bone Turnover

D. Mancini, E. Shane, D. McMahon, 2006, Transplantation.

Heart Retransplantation

Mark Johnson, D. Mancini, C. Canter, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Detection and imaging of cardiac allograft vasculopathy.

G. Weisz, D. Mancini, Tamim Nazif, 2013, JACC. Cardiovascular imaging.

Differences in Regional Recipient Waitlist Time and Pre- and Post-Transplant Mortality Following the 2006 UNOS Policy Changes in the Donor Heart Allocation Algorithm

Zhezhen Jin, D. Mancini, P. Schulze, 2014 .

Higher rate of comorbidities after cardiac retransplantation contributes to decreased survival.

N. Uriel, D. Mancini, K. Leitz, 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Immunoglobulin Mto-Immunoglobulin G Anti-Human Leukocyte Antigen Class II Antibody Switching in Cardiac Transplant Recipients Is Associated With an Increased Risk of Cellular Rejection and Coronary Artery Disease

D. Mancini, R. John, S. Itescu, 2005 .

Challenges in heart transplantation during COVID-19: A single-center experience

D. Mancini, A. Lala, S. Pinney, 2020, The Journal of Heart and Lung Transplantation.

Sixteen years of cardiac transplantation: the Columbia Presbyterian Medical Center experience 1977 to 1993.

D. Mancini, R. Michler, J. Chen, 1993, Clinical transplants.

Increased levels of retinol binding protein 4 in patients with advanced heart failure correct after hemodynamic improvement through ventricular assist device placement.

D. Mancini, T. Kato, P. Schulze, 2011, Circulation journal : official journal of the Japanese Circulation Society.

Use of Ventricular Assist Devices in Patients with Mitral Valve Prostheses

N. Uriel, D. Mancini, A. Goda, 2011, Journal of cardiac surgery.

Aortic valve procedures at the time of ventricular assist device placement.

N. Uriel, D. Mancini, A. Goda, 2011, The Annals of thoracic surgery.

The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection.

D. Mancini, C. Marboe, S. Restaino, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation.

M. Mack, A. Moskowitz, P. O'Gara, 2019, Journal of the American College of Cardiology.

72 Degree of End Organ Damage as a Predictor of Outcomes after Mechanical Circulatory Support Device Implantation – A More Quantitative Assessment

A. Sinha, D. Mancini, T. Kato, 2011 .

Concomitant aortic valve repair with continuous-flow left ventricular assist devices: Results and implications.

D. Mancini, Y. Naka, H. Takayama, 2016, The Journal of thoracic and cardiovascular surgery.

Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database).

Zhezhen Jin, Zhezhen Jin, D. Mancini, 2014, The American journal of cardiology.

Increased Prevalence of Autoimmune Phenomena and Greater Risk for Alloreactivity in Female Heart Transplant Recipients

D. Mancini, R. John, S. Itescu, 2001, Circulation.

Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry.

D. Mancini, Y. Naka, J. Dizon, 2017, JACC. Heart failure.

The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis.

D. Mancini, Y. Naka, J. Dizon, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Is Lactate Level during Warm Perfusion a Predictor for Post Transplant Outcomes

P. Leprince, D. Mancini, M. Camacho, 2013 .

De novo human leukocyte antigen allosensitization patterns in patients bridged to heart transplantation using left ventricular assist devices.

D. Mancini, A. Lala, S. Pinney, 2022, Transplant immunology.

Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device.

D. Mancini, Y. Naka, H. Takayama, 2016, The Journal of thoracic and cardiovascular surgery.

Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.

D. Mancini, M. Jessup, M. Mehra, 2007, American heart journal.

Surgically denervated cardiac transplant. Rewired or permanently unplugged?

D. Mancini, 1997, Circulation.

Abstract 2310: Peak Cardiac Power, Measured Non-Invasively, Is A Powerful Predictor Of Mortality In Chronic Heart Failure

C. Lang, D. Mancini, W. Levy, 2007 .

Improved atrial function in bicaval versus standard orthotopic techniques in cardiac transplantation.

D. Mancini, S. Homma, M. D. Di Tullio, 1997, The American journal of cardiology.

Value of Serial Echo‐Guided Ramp Studies in a Patient with Suspicion of Device Thrombosis after Left Ventricular Assist Device Implantation

N. Uriel, D. Mancini, S. Homma, 2014, Echocardiography.

Should HIV-positive recipients undergo heart transplantation?

M. Oz, D. Mancini, J. Morgan, 2003, The Journal of thoracic and cardiovascular surgery.

Post-transplant survival estimation using pre-operative albumin levels.

D. Mancini, T. Kato, P. Schulze, 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation.

D. Mancini, T. Kato, P. Schulze, 2013, The American journal of cardiology.

Patients With End Stage Congestive Heart Failure Have Decreased High Molecular Weight Von Willebrand Factor Multimers and Higher Plasma Levels Of Total TGF-β1: Implantation Of a Left Ventricular Assist Devices (LVAD) Exacerbates Both Abnormalities

D. Mancini, B. Coller, M. Suárez-Fariñas, 2013 .

Cardiac transplantation in an HIV-1-infected patient.

D. Mancini, J. Morgan, G. Bisleri, 2003, The New England journal of medicine.

Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation.

J. Schwartz, D. Mancini, J. Goin, 1997, Circulation.

The Impact of Donor Specific Antibodies on Antibody Mediated Rejection

D. Mancini, C. Marboe, S. Restaino, 2016 .

Benefit of selective respiratory muscle training on exercise capacity in patients with chronic congestive heart failure.

D. Mancini, S. Levine, D. Mancini, 1995, Circulation.

Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

William T. Abraham, Peter S. Rahko, Marvin A. Konstam, 2013 .

Safety and effects of SGLT-2 inhibitor use among LVAD patients with type 2 diabetes mellitus

D. Mancini, A. Lala, N. Moss, 2022, American Heart Journal Plus: Cardiology Research and Practice.

192 Psychosocial Evaluation before Left Ventricular Assist Device Implantation Can Predict Device Complication during Support

N. Uriel, D. Mancini, Y. Naka, 2011 .

Characteristics of patients with advanced heart failure having eosinophilic infiltration of the myocardium in the recent era.

D. Mancini, S. Yoshizawa, Tomoko Sugiyama Kato, 2013, International heart journal.

Ablation of Ventricular Tachycardia Originating From the Papillary Muscle of the Left Ventricle Early After Heart Transplantation

D. Mancini, H. Garan, V. Iyer, 2014, Circulation. Heart failure.

Comparison Between Cardiac Allograft Vasculopathy and Native Coronary Atherosclerosis by Optical Coherence Tomography.

T. Nazif, Z. Ali, G. Weisz, 2016, The American journal of cardiology.

Optical Coherence Tomographic Evaluation of Transplant Coronary Artery Vasculopathy With Correlation to Cellular Rejection

T. Nazif, J. Moses, G. Weisz, 2014, Circulation. Cardiovascular interventions.

Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database).

Zhezhen Jin, D. Mancini, P. Schulze, 2014, The American journal of cardiology.

Infectious complications after cardiac transplantation in patients bridged with mechanical circulatory support devices versus medical therapy.

D. Mancini, M. Farr, S. Restaino, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

HFpEF: is splitting into distinct phenotypes by comorbidities the pathway forward?

D. Mancini, M. Maurer, 2014, Journal of the American College of Cardiology.

Increased Prevalence of Autoimmune Phenomena and Greater Risk for Alloreactivity in Female Heart Transplant Recipients

D. Mancini, R. John, S. Itescu, 2001, Circulation.

Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity?

V. Fuster, J. Sanz, J. Badimón, 2019, Cardiovascular Drugs and Therapy.

Intravenous immunoglobulin therapy in highly sensitized cardiac allograft recipients facilitates transplantation across donor specific IGG positive cross matches.

M. Oz, D. Mancini, Y. Naka, 2001, The Journal of Heart and Lung Transplantation.

Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era: Implications for Patient Selection

A. Kfoury, D. Mancini, M. Slaughter, 2007, Circulation.

Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.

N. Uriel, D. Mancini, S. Susen, 2010, Journal of the American College of Cardiology.

Bridge-to-Decision Therapy With a Continuous-Flow External Ventricular Assist Device in Refractory Cardiogenic Shock of Various Causes

N. Uriel, T. Ota, D. Mancini, 2014, Circulation. Heart failure.

Signal-Averaged Electrocardiogram in Patients With Nonischemic Congestive Cardiomyopathy

D. Mancini, M. Simson, Kar-Lai Wong, 2005 .

Serial echocardiography using tissue Doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery.

N. Uriel, D. Mancini, S. Homma, 2013, JACC. Heart failure.

Cardiac rehabilitation exercise and self-care for chronic heart failure.

S. Keteyian, M. Rich, G. Balady, 2013, JACC. Heart failure.

The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.

D. Burkhoff, J. D’Armiento, D. Mancini, 2007, Journal of the American College of Cardiology.

Consensus recommendations for the management of chronic heart failure: Introduction

R. Falk, G. Fonarow, P. Kowey, 1999 .

Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.

D. Mancini, T. Kato, P. Schulze, 2013, Journal of the American College of Cardiology.

234: Effect of clenbuterol on cardiac and skeletal muscle function during LVAD support

C. Petrilli, M. Oz, D. Mancini, 2006 .

Bridging to Transplant With Fully Implantable Biventricular Assist Devices vs. Total Artificial Heart Implantation in Patients With Advanced Biventricular Failure

D. Mancini, O. Wever-Pinzon, Y. Naka, 2015 .

Frailty Measures of Patient-reported Activity and Fatigue May Predict 1-year Outcomes in Ambulatory Advanced Heart Failure: A Report From the REVIVAL Registry.

M. Yosef, D. Mancini, D. Mann, 2021, Journal of cardiac failure.

Persistence of Cheyne-Stokes breathing after left ventricular assist device implantation in patients with acutely decompensated end-stage heart failure.

D. Mancini, R. Basner, M. Padeletti, 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Left Ventricular Assist Devices: A Rapidly Evolving Alternative to Transplant.

D. Mancini, P. Colombo, 2015, Journal of the American College of Cardiology.

The Proportion of BNP Decline after Left Ventricular Assist Device Implantation Predicts Length of Survival after Surgery

D. Mancini, T. Kato, Y. Naka, 2010 .

Cardiac transplantation in adult patients with mental retardation: do outcomes support consensus guidelines?

D. Mancini, P. Shapiro, Emma Samelson-Jones, 2012, Psychosomatics.

Impact of LVAD speed change on physiologic functions.

D. Mancini, N. Moss, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Concomitant aortic valve repair with continuous-flow left ventricular assist devices: Results and implications.

D. Mancini, Y. Naka, H. Takayama, 2016, The Journal of thoracic and cardiovascular surgery.

Relation of Left Ventricular Assist Device Infections With Cardiac Transplant Outcomes.

D. Mancini, A. Lala, M. Trivieri, 2021, The American journal of cardiology.

Amiodarone Treatment Prior to Heart Transplantation Is Associated with Acute Graft Dysfunction and Early Mortality: A Propensity-Matched Comparison

N. Uriel, D. Mancini, P. Schulze, 2014 .

Survival of diabetic patients following cardiac transplant.

D. Mancini, J. Chen, N. Edwards, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Everolimus dose recommendations in de novo heart transplantation - TDM simulations

D. Renlund, D. Mancini, R. Starling, 2003 .

Alloantibody Desensitization Therapy in Bridge-to-Transplant Patients on Continuous-Flow Left Ventricular Assist Device Support

D. Mancini, M. Farr, M. Maurer, 2016 .

Perceived control and health-related quality of life in heart transplant recipients

D. Mancini, J. Kobashigawa, L. Doering, 2018, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

The New Adult Heart Allocation Policy: A Work in Progress.

D. Mancini, Monica M Colvin, 2020, Circulation. Cardiovascular quality and outcomes.